Oct 10, 2025Press Release The company's Portsmouth footprint includes a 10,000-sq-ft facility with an ISO Class 8 clean room supporting platform development. | Oct 10, 2025 | Press Release | The company's Portsmouth footprint includes a 10,000-sq-ft facility with an ISO Class 8 clean room supporting platform development. | ||
Dec 20, 2024News Pirouette Pharma's naloxone auto-injector named 2024 Product of the Year by the NH Tech Alliance at a live event with nearly 800 attendees. | Dec 20, 2024 | News | Pirouette Pharma's naloxone auto-injector named 2024 Product of the Year by the NH Tech Alliance at a live event with nearly 800 attendees. | ||
Jun 26, 2024News Featured by NIH SEED on the NIH Innovation Zone stage at BIO International 2024 for safer, easier auto-injections. | Jun 26, 2024 | News | Featured by NIH SEED on the NIH Innovation Zone stage at BIO International 2024 for safer, easier auto-injections. | ||
May 7, 2024News Safar Partners led a community round surpassing $5M, enabling patients and clinicians to invest alongside institutional backers. | May 7, 2024 | News | Safar Partners led a community round surpassing $5M, enabling patients and clinicians to invest alongside institutional backers. | ||
Pirouette is building for chronic, at‑home adherence and partner differentiation: OnePush hides a fully automatic needle before, during, and after use, reducing injection anxiety to drive patient preference, brand loyalty, and persistency. The platform strategy aims to unlock value via abbreviated regulatory pathways (505(b)(2)/351(k)), device‑driven adherence, and scalable U.S. manufacturing across chronic, rescue and warfighter categories.
